Who are we
LS-SACS helps organizations design AI strategies, align operating models, establish risk-based governance, and guides the leadership and operational teams through the complexities of AI adoption in a regulatory complaint manner.
Partner with us in translating your enterprise AI vision into customized operating models and pilot initiatives that deliver tangible business outcomes : Improved operational efficiency & reduced cost, reduced time to submissions and successful approvals, improved patient, staff satisfaction, and competitive advantage.
LS-EAT: Enterprise AI Transformation Assessment
LS-SACS has developed Life Sciences – Enterprise AI Transformation Assessment (LS-EATA) with a goal to help life sciences companies move rapidly and in a systematic fashion from disconnected AI pilots into an AI-powered and adaptive enterprise. LS-EATA-led transformation approach links strategy, operating model, data and technology, people, trust, compliance, execution and measurable value.
LS-EATA is part of LS-SACS' enterprise AI transformation intelligence system that covers the 6 major pillars and encompass Enterprise AI capability and 5 maturity stages. Our scoring approach ensures traceability of stakeholders' scoring to evidence, separate from priorities. Insight-driven analysis leads to the transformation roadmap that is customized to the individual organization and successful realization of the transformation goals.
Business Strategy, EBITDA Improvement, Value Creation
​
(For SaaS, Services, Venture Capital and Private Equity Clients)
Client Testimonials
"I worked with LS-SACS on a couple of programs where we implemented Ai-based digital technology solutions in the clinical trials space. He was an excellent partner who genuinely fostered a collaborative atmosphere. He and his team went the extra mile in helping us tailor the solution to our needs and implemented cutting edge technologies to create data visualization tools. Krishnan had a keen interest in this area and will be of great help to health care companies looking to move into time data visualization and analysis of clinical trial data"
Dr. Niranjan Rao, Senior Vice President, Development Sciences at Asana Biosciences, LLC.
Rajesh Ghosh, Head, Digital Safety and Decision Support at Genentech
"I had the pleasure of working with Krishnan, during my tenure as head of Integrated Medical Safety at Novartis. Krishnan consulted and collaborated with me and our senior pharmacovigilance leadership team in conducting an Outsourceability Portfolio Analysis (OPA) of all the safety activities. His understanding of digital transformation, global sourcing and outsourcing market, various engagement models, consultative and objective approach combined with his domain expertise was instrumental in the design of “Optimal Future state” PV operating model for us. I would gladly collaborate with him in any future consulting or sourcing project"
"I had the pleasure of working with LS-SACS and Krishnan during my tenure at Organon. Krishnan consulted and collaborated with me, our senior procurement, strategic sourcing, business and legal teams, and category leaders across multiple activities:. His understanding of the clinical, regulatory, pharmacovigilance functional operating models, global sourcing and outsourcing market, various engagement and contractual models and his collaborative / flexible approach in working with procurement and business leaders was evident throughout our partnership with him. I would gladly collaborate with him and LS-SACS in any future strategy, business consulting or sourcing project"
Mary Lynne Bercik - Executive Director of R&D Global Procurement and Supplier Management, Organon
Why Choose LS-SACS ?
Improved Strategic Outcomes
Best In Class Integrated Consulting + Domain Expertise
Data Driven Insights
Holistic & Data Driven Insights
Flexible, Scalable &
On Demand Staffing
Expert Advice & Execution Excellence
Customized & Collaborative
"Customer-Delight"
Leadership & Team
LS-SACS leverages a broad network of industry leaders and SMEs on an "on-demand" across clinical operations, clinical data sciences, pharmacovigilance, regulatory operations, procurement and other areas. The network includes an extended team of business process transformation, operating model and redesign, staffing roles and responsibilities and training, organizational change and communications and digital, AI / ML technology experts.
​​
​Dr. Krishnan Rajagopalan, Ph.D.,
President, LS-SACS
​
Dr. Krishnan Rajagopalan has over 30 years of experience in Strategic Advisory / management consulting, global services delivery (CRO, FSP and IT services) and sourcing / outsourcing services to the Life Sciences industry (Pharma, biotech, medical devices, and generics). He advised and provided services to more than 120 small, medium, and large life sciences organizations across research, clinical development, and commercial functions.
Prior to LS - SACS, Krishnan was an advisor and global practice leader at Navitas Life Sciences, Cognizant, PA Consulting, Infosys and Mitchell Madison Group​​Dr. Rajagopalan has a Ph.D., in Bio organic chemistry from the University of Kentucky and was a NCI Cancer Research Fellow at the Harvard Medical School and Massachusetts General Hospital. He has more than 20 peer reviewed publications and presentations and a US Patent​​​​​​​​​​​​.
